Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NL-OMON44063Phase 2Withdrawn
Phase 2, open-label, single-arm trial in perianal dermatitis, sponsored by Erasmus MC. Primary endpoint: Improvement of perianal dermatitis. Planned start Feb 2016; status: withdrawn.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NL-OMON44063.